This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Farsight Medical Technology (Shanghai) Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Ching Pong Mak: Innovator in Nephrotoxin-Induced Kidney Injury Treatment
Introduction
Ching Pong Mak is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medical technology, particularly in the treatment and prevention of kidney injuries caused by nephrotoxins. His innovative approach has the potential to improve patient outcomes in this critical area of healthcare.
Latest Patents
Ching Pong Mak holds a patent for a groundbreaking invention titled "Treatment and prevention of nephrotoxin-induced kidney injuries." This patent involves Compound I or a pharmaceutically acceptable salt thereof, which is designed for use in the prevention and/or treatment of kidney conditions or diseases in subjects exposed to nephrotoxins. This invention addresses a pressing medical need and showcases Mak's commitment to advancing healthcare solutions.
Career Highlights
Ching Pong Mak is associated with Farsight Medical Technology (Shanghai) Co., Ltd., where he applies his expertise in developing innovative medical treatments. His work at this company reflects his dedication to improving medical technologies and patient care.
Collaborations
Ching Pong Mak collaborates with talented professionals in his field, including Michael Robert Peel and Fashu Ma. These partnerships enhance the development of innovative solutions in medical technology.
Conclusion
Ching Pong Mak's contributions to the treatment of nephrotoxin-induced kidney injuries highlight his role as an influential inventor in the medical field. His patent and ongoing work at Farsight Medical Technology demonstrate his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile